| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.003 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.098 | 0.004 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.16 | 0.004 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.005 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.086 | 0.005 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.006 |